The skin gateway
to the Immune System

What's New ?

January, 31 2012


DBV Technologies announces the filing of its “Document de Base” with the French Autorité des marchés financiers (the “AMF”) for proposed Initial Public Offering on the regulated market of NYSE Euronext in Paris More

Video Library

A revolutionary approach in allergy treatment

11 to 26 million people suffer from food allergy in Europe while at the global level, the estimate is 220 to 500 million people. 3 to 5% of Americans suffer from food allergies and the prevalence of peanut allergy in children has almost quadrupled from 1997 to 2008…

Legal Mention

CNIL number: 1544201 v 0

DBV technologies - siège social
Green Square - Bâtiment D
80/84 rue des Meuniers
92220 Bagneux
France
Phone: +33 (0)1 55 42 78 78
Fax: +33 (0)1 43 26 10 83

SIRET: 441772522 00013
RCS: Nanterrre

Executive editor: Pierre-Henri Benhamou

Hosting service: OVH www.ovh.com

Design : l’enchanteur www.lenchanteur.com

Contact


Share